# GPT-5.4 (R1) Review

**Role:** External referee review
**Model:** openai/gpt-5.4
**Paper:** paper.pdf
**Timestamp:** 2026-03-10T13:29:10.516969
**Route:** OpenRouter + LaTeX
**Review mode:** Tri-model (3 independent reviewers)
**Tokens:** 20283 in / 5304 out
**Response SHA256:** b8446c7219845ffb

---

This paper studies whether the EU’s 2014 public procurement directives increased competition, exploiting staggered national transposition dates across EU member states and TED award notices from 2009–2023. The paper is ambitious in scope, uses a very large underlying dataset, and applies modern staggered-DiD tools. The central empirical finding is a null reduced-form association between transposition timing and standard competition outcomes, especially single-bidder rates and bidder counts.

The topic is important and well suited in principle for a general-interest or policy journal: public procurement is quantitatively large, the reform is high-profile, and the paper’s headline question is consequential. I also appreciate that the paper does not attempt to hide uncomfortable diagnostics: it explicitly reports a significant pre-trend test, and it is commendably transparent about the possibility that legal transposition is an imperfect proxy for actual implementation.

That said, in its current form I do not think the paper is publication-ready for a top field/general-interest outlet. The core concern is that the identifying variation—cross-country timing of legal transposition—is not yet shown to be credible for the substantive causal claim the paper wants to make. The paper is strongest as a descriptive reduced-form study of legal transposition timing and weakest when it interprets the null as evidence that “procedural reform” did not increase competition or that “structural barriers dominate procedural ones.” Given the significant pre-trends, severe treatment-timing mismatch, compressed treatment window, and all-treated staggered design, the current evidence does not support that stronger interpretation.

## 1. Identification and empirical design

### A. The central identification assumption is not sufficiently credible as currently defended
The key assumption is that conditional on country and time fixed effects, transposition timing is unrelated to changes in procurement outcomes (\S4.1). This is a strong claim. The paper argues that delays reflected “legislative capacity, parliamentary calendars, and political priority,” and that these are “largely unrelated” to procurement competition trends. That is asserted rather than demonstrated.

In this setting, the plausibility problem is substantive, not merely econometric. Countries that transposed earlier may differ systematically in administrative modernization, e-procurement readiness, public sector digitization, procurement professionalism, legal capacity, or ongoing anti-corruption reform. Those same factors could affect competition trends directly. The paper’s own heterogeneity analysis by government effectiveness (\S5.3) points toward exactly the kinds of institutional differences that could jointly shape transposition timing and procurement outcomes. The paper needs much stronger evidence that transposition timing is orthogonal to potential outcomes.

Concretely, I would want to see:
- predictors of transposition timing using pre-2014 observables;
- whether transposition timing is correlated with pre-reform trends in single-bid rates, bidder counts, digitization, contract composition, or reporting completeness;
- whether countries with pre-existing e-procurement systems transposed earlier and were already on different competition trajectories.

Right now, the design relies too heavily on institutional narrative.

### B. The treatment is likely badly mismeasured relative to the economic reform
This is the most serious substantive design problem. The treatment is the date national implementing legislation entered into force, activated from the first full quarter after transposition (\S3.2, \S4.3). But the directive bundled multiple provisions that likely took effect on different calendars:
- e-submission and digital procurement rollouts often required technical implementation beyond legal transposition;
- contracting authorities may have phased in provisions with delay;
- many awarded contracts post-transposition were initiated pre-transposition, especially given long procurement cycles;
- some countries had already implemented parts of the reform de facto before formal transposition.

The paper acknowledges this in \S6.4 (“treatment timing mismatch could attenuate estimates toward zero”), but this is not a minor caveat; it is central. If legal transposition is a weak proxy for actual exposure, then the study may be underpowered to detect meaningful effects even with a huge micro dataset, because identification occurs at the country-time level with only 28 countries and limited effective treatment variation.

This timing issue also weakens the no-anticipation assumption in \S4.1. Even if firms do not respond before formal transposition, contracting authorities may adopt practices before legal transposition, especially where implementation preparation was underway. Conversely, after transposition, authorities may still operate under old systems for months. The paper needs either:
1. a much better treatment measure, or
2. a sharper reframing as a study of legal transposition timing rather than reform implementation.

At present, the paper oscillates between those two interpretations.

### C. Significant pre-trends are a major problem, not a secondary caveat
The paper reports a joint pre-trend test with \(p<0.001\) (\S1, \S4.4, \S6.4). That is a serious warning sign. The current response—“pre-existing trends do not invalidate the null finding”—is too dismissive. They do not mechanically overturn the null, but they do undermine causal interpretation and precision claims.

Two related concerns:

1. The paper argues pre-trend magnitudes are “small” and “non-monotonic.” But with the outcome mean around 0.265, even 1–2 percentage-point movements are not negligible relative to the policy-relevant range.

2. The Rambachan-Roth intervals reported in \S5.4 and Appendix B become very wide under modest violations. At \(\bar M=2\), the interval is \([-0.213,0.267]\), which is far too wide to support strong substantive conclusions. That bound no longer supports “no meaningful effect”; it supports “the design is not very informative under plausible trend deviations.”

This is important for claim calibration. Under exact parallel trends, the estimate is precise. Once the paper admits the parallel trends evidence is poor, the effective informativeness declines sharply. The paper should not simultaneously emphasize the strong pre-trend rejection and then continue to present the narrow TWFE confidence interval as dispositive.

### D. The staggered design is compressed and all-treated, which limits leverage
All countries are eventually treated, and transposition is concentrated within roughly 2015Q4–2018Q3. This leaves:
- a relatively short untreated comparison window around treatment;
- no never-treated group;
- limited support for longer-run event-time effects;
- possible contamination from common EU-wide implementation dynamics around the 2016 deadline.

The paper notes that Callaway-Sant’Anna effectively uses only ten cohort groups (\S5.2), despite 28 dates. That is revealing: the identifying variation is much thinner than the raw contract count suggests. This should temper the paper’s confidence.

The Goodman-Bacon decomposition showing 90.4% weight on treated-vs-untreated comparisons is helpful but not sufficient. In an all-treated, compressed-timing setting, “not-yet-treated” controls may still be poor controls if countries are on differential trends or pre-implementing.

### E. The unit of analysis and weighting deserve more justification
The paper aggregates to country-quarter and weights by number of contracts (\S3.3, \S4.2). That is sensible in some respects, but it changes the estimand. The weighted specification largely reflects high-volume procurement systems. It would be useful to clarify whether the target is:
- the average effect on the average contract,
- the average effect on the average country-quarter, or
- something else.

Given the strong cross-country heterogeneity in procurement volume (Table 2), weighted and unweighted estimates could differ materially. The paper says weighting is robust in Appendix C but does not report the alternative estimate directly. That should be shown in the main robustness table.

### F. Sample coverage and panel structure may interact with treatment timing
The panel is substantially unbalanced (Appendix A): 1,189 country-quarters versus 1,680 in a balanced panel. Missingness arises from Croatia’s accession, low-volume small states, and weaker early TED coverage. This creates two concerns:
- early pre-period support differs by country and may correlate with treatment timing;
- changes in reporting completeness could mechanically affect outcomes like bidder counts and SME status.

This matters especially because treatment and data quality both improve over time in TED. The paper needs to show that the main results are not artifacts of evolving reporting coverage or changing variable completeness.

## 2. Inference and statistical validity

### A. Main uncertainty reporting is present, but inference should rely less on asymptotic country-cluster SEs
The paper reports standard errors and sample sizes consistently in the main tables. That is good.

However, with only 28 country clusters, conventional cluster-robust SEs should not be the primary basis for inference. The paper does report randomization inference and a pairs cluster bootstrap in appendices/robustness, which is valuable. But if the paper wants to make strong inferential statements, the wild cluster bootstrap (or a similarly standard small-cluster method) should be front-and-center for the main estimates, not an auxiliary afterthought. The current robustness table reports “WCB p-value = 1.00” but the text refers mostly to RI and conventional SEs. Small-cluster inference should be integrated into the main presentation.

### B. The paper handles the staggered-DiD literature responsibly, but the robust estimator is less reassuring than presented
It is good that the paper does not rely exclusively on TWFE. It uses Callaway-Sant’Anna, Sun-Abraham, and Goodman-Bacon.

Still, the interpretation is overly comforting:
- The C-S ATT for the primary outcome is 0.0365 with SE 0.0404 (Table 4), materially less precise than TWFE and not especially tightly centered near zero.
- For SME share, the C-S estimate differs sharply from TWFE. The paper attributes this to one cohort, which may be right, but this disagreement should reduce confidence in estimator stability rather than be brushed aside.
- In an all-treated design with compressed adoption, even heterogeneity-robust estimators are not a panacea.

So while I agree the paper appropriately rejects naive TWFE as the sole basis, I do not think the alternative estimators rescue identification in a strong way.

### C. Placebo timing tests are not very informative in the presence of pre-trends and treatment mismeasurement
The placebo shifts of -4 and -8 quarters are nice to report, but they do not overcome the main concern. If implementation is gradual and treatment timing is noisy, placebo date shifts may remain null even when the design is weak. Likewise, in the presence of non-monotonic differential trends, insignificant placebo estimates are not especially diagnostic.

### D. Outcome construction and reporting need more inferential transparency
For several outcomes:
- SME share is available for only 984 country-quarters (Table 3; Table 2 notes differential reporting).
- Processing days is available for only 853 observations.
- Award ratio is winsorized, but there is little discussion of missing estimated values, changes in valuation reporting, or comparability across countries.

For the SME and award-ratio outcomes in particular, one needs more evidence that sample composition is stable and not itself affected by treatment/reporting reforms. Otherwise the nulls or sign changes may partly reflect reporting selection.

## 3. Robustness and alternative explanations

### A. The robustness menu is broad, but several key robustness exercises are missing
The paper includes many checks, but several high-value ones are absent:

1. **Country-specific linear trends**  
   Given the strong pre-trend evidence, a specification with country-specific trends is essential, even if imperfect. I would not treat it as dispositive, but it is a necessary robustness check.

2. **Short-window/event-window designs**  
   Restricting the sample to a narrower window around transposition (e.g., two years pre/post) may reduce contamination from long-run secular changes and early TED data quality shifts.

3. **Exclusion of early poor-coverage years**  
   Since TED structured data are weaker in 2009–2010 (Appendix A), re-estimating from 2011 or 2012 onward is important.

4. **Unweighted results**  
   These should be shown clearly.

5. **Alternative treatment codings**  
   Since many contracts are initiated before award, outcomes should be aligned to notice date where possible, or the treatment should be lagged materially.

6. **Contract-level estimation with richer controls**  
   The CPV-fixed-effects robustness is helpful, but the paper should present contract-level specifications with country × year or sector × time controls if feasible.

### B. Mechanism interpretation is too speculative relative to the evidence
The paper’s main mechanism interpretation is that “structural entry barriers dominate procedural ones” (\S1, \S6.1, \S7). This is plausible, but the paper does not test it directly. At most, the results show that variation in legal transposition timing is not strongly associated with aggregate competition outcomes. That is not enough to conclude that structural barriers dominate.

The high/low administrative capacity split also does not isolate mechanisms cleanly. A null in high-capacity countries does not prove implementation is irrelevant; it may mean:
- legal transposition timing is still a bad measure of practical implementation even in high-capacity states,
- high-capacity states had already implemented similar systems before formal transposition,
- effects occur in specific sectors or buyer types that aggregate away.

Mechanism claims need to be more clearly labeled as conjectures.

### C. Alternative explanations for the null remain underexplored
The paper discusses some, but more is needed:
- **pre-existing reform saturation**: countries may already have adopted e-procurement or simplification;
- **simultaneous macro/political shocks**: post-2014 Europe includes migration crisis, Brexit, COVID, inflation, recovery funds;
- **reporting changes rather than bidding changes**: especially for SME status and bid counts;
- **sectoral heterogeneity**: effects may differ across works, services, and supplies.

A null aggregate effect could mask offsetting sectoral effects. Given the policy design, this is not a minor possibility.

## 4. Contribution and literature positioning

The paper’s potential contribution is real: EU-wide evaluation of a major procurement reform using modern DiD methods and a very large administrative dataset. That is novel and important.

That said, the literature positioning would benefit from a slightly sharper distinction between:
1. studies of **advertising/threshold/discretion** margins, and
2. studies of **procedural simplification and digitalization** margins.

The paper already cites useful procurement references, but there are a few literatures/papers that should be engaged more explicitly if the paper is revised:

- **Roth, Sant’Anna, Bilinski, Poe (2023, JEL/related survey literature on DiD diagnostics and pretrends)**: useful for framing why pre-trend rejection changes interpretation, not just for citing Roth (2022).
- **de Chaisemartin and D’Haultfoeuille follow-up papers** on staggered adoption estimands and treatment effect heterogeneity: especially relevant because all units are eventually treated.
- **Procurement digitalization/e-procurement evidence** beyond the classic publicity papers, if available in the policy literature, since e-procurement is one of the main channels claimed by the directive.
- **Decarolis and related procurement auction literature** if the paper wants to make stronger claims about entry costs, bidder participation, or market structure.

I would not say the literature review is inadequate, but it should better connect the identification challenge to the now-standard DiD diagnostic literature, and it should better situate the paper vis-à-vis e-procurement implementation studies.

## 5. Results interpretation and claim calibration

This is where the paper most needs tightening.

### A. The headline null should be stated more cautiously
The abstract and conclusion mostly say “no detectable reduced-form association,” which is appropriate. But elsewhere the paper slides toward stronger statements:
- “the reform failed to improve competition”
- “procedural reform is insufficient”
- “structural barriers dominate procedural ones”
- “the procedural levers have been pulled”

These claims go beyond what the design supports, given:
- significant pre-trends,
- treatment timing mismatch,
- wide robust/sensitivity intervals,
- all-treated compressed adoption,
- possible implementation heterogeneity.

The paper identifies at best the effect of **legal transposition timing**, not the effect of the substantive reform package as actually implemented.

### B. The paper overstates precision in some places
The narrow TWFE CI for single-bid share is informative only under strong assumptions. Once the paper presents Rambachan-Roth intervals that widen dramatically, the interpretation should shift. The paper cannot both say “we rule out effects larger than 2.5 percentage points” and also concede that under plausible violations the interval spans roughly -21 to +27 points. The former is conditional precision; the latter is robustness-adjusted uncertainty. The paper needs to present these as distinct inferential objects and not let the reader come away with an exaggerated sense of precision.

### C. The award-ratio result is overinterpreted
A 10% significant effect on one of several outcomes should be framed as suggestive at best. Given multiple outcomes and concerns about estimated-value reporting, I would not highlight this as evidence of “improved value extraction” without substantially more support.

### D. The SME result requires much more caution
The paper is appropriately somewhat cautious, but not enough. A sign reversal between TWFE and C-S, driven by one cohort and with missing outcome data for many country-quarters, should be framed as unstable and exploratory. It is not yet a credible secondary contribution.

## 6. Actionable revision requests

### 1. Must-fix issues before acceptance

**1. Reframe the causal claim around legal transposition timing unless a better treatment measure can be built.**  
- **Why it matters:** Current claims often read as causal effects of the substantive reform package, but the treatment is legal transposition, which is an imperfect and likely noisy proxy for implementation.  
- **Concrete fix:** Rewrite the empirical claim throughout as the effect of legal transposition timing on outcomes, and sharply separate this from the structural reform effect. Alternatively, construct provision-specific or implementation-based treatment dates (e-procurement rollout, ESPD adoption, etc.) if feasible.

**2. Address the pre-trend failure much more seriously.**  
- **Why it matters:** \(p<0.001\) on pre-trends materially undermines the design.  
- **Concrete fix:** Add specifications with country-specific linear trends; add narrow-window analyses; show estimates dropping early years with weaker TED coverage; report how the main estimate changes under these alternatives; move the robustness-adjusted interpretation into the abstract/conclusion.

**3. Provide evidence on the determinants of transposition timing.**  
- **Why it matters:** The core identification assumption is currently asserted, not demonstrated.  
- **Concrete fix:** Regress transposition timing on pre-2014 procurement outcomes, pre-trends, administrative capacity, digitization/e-procurement readiness, corruption/institutions, and procurement volume. Show that timing is or is not systematically related to observables. If it is, that must reshape interpretation.

**4. Improve treatment timing alignment with procurement cycles.**  
- **Why it matters:** Award outcomes post-transposition may reflect tenders launched pre-transposition.  
- **Concrete fix:** Where possible, re-define outcomes by contract notice date rather than award date, or impose treatment lags (e.g., 2–4 quarters after transposition) and show robustness. A distributed-lag/event-time design centered on notice-date exposure would be even better.

**5. Integrate small-cluster inference into the main results.**  
- **Why it matters:** With 28 clusters, conventional clustered SEs are not enough for publication-ready inference.  
- **Concrete fix:** Report wild cluster bootstrap p-values or confidence intervals for all main estimates in the main table.

### 2. High-value improvements

**6. Report unweighted and weighted estimands side by side.**  
- **Why it matters:** Weighting by contract count changes the estimand and may privilege large countries.  
- **Concrete fix:** Add a table showing weighted vs. unweighted TWFE/C-S estimates.

**7. Probe reporting/composition changes directly.**  
- **Why it matters:** TED reporting completeness may change over time and with reform.  
- **Concrete fix:** Use missingness rates, reporting shares, and publication intensity as outcomes/placebos; show whether transposition affects the number of reported contracts, missing bidder counts, missing SME status, or estimated-value availability.

**8. Explore heterogeneity by sector/procedure/buyer type.**  
- **Why it matters:** The directive plausibly affected some margins more than others; aggregate nulls may hide offsetting effects.  
- **Concrete fix:** At minimum, split by works/supplies/services, and by open vs. restricted/negotiated procedures. If the theory is SME access, lot-prone sectors would be particularly relevant.

**9. Shorten and sharpen the interpretation of Goodman-Bacon and randomization inference.**  
- **Why it matters:** These are useful diagnostics but do not solve endogeneity or timing mismatch.  
- **Concrete fix:** Present them as supplementary checks rather than as core evidence for identification.

**10. Clarify outcome validity, especially award ratio and SME share.**  
- **Why it matters:** These outcomes are vulnerable to inconsistent reporting and sample selection.  
- **Concrete fix:** Add appendix diagnostics on reporting completeness by country-year and whether this changes at transposition.

### 3. Optional polish

**11. Consolidate the inferential hierarchy.**  
- **Why it matters:** The paper currently alternates between narrow TWFE precision and wide robustness bounds.  
- **Concrete fix:** Explicitly distinguish “baseline under exact parallel trends” from “robust under trend violations.”

**12. Tighten mechanism language.**  
- **Why it matters:** Structural-barriers interpretation is suggestive, not proven.  
- **Concrete fix:** Replace strong declarative statements with language such as “consistent with” and “one possible interpretation.”

**13. Make the contribution statement more precise.**  
- **Why it matters:** The paper’s strongest contribution is a transparent EU-wide evaluation of legal transposition timing using modern DiD diagnostics.  
- **Concrete fix:** Emphasize that contribution rather than broader claims about procurement reform writ large.

## 7. Overall assessment

### Key strengths
- Important policy question with broad interest.
- Impressive data scope and clear institutional setup.
- Good use of modern staggered-DiD tools relative to much older procurement work.
- Transparent reporting of inconvenient diagnostics, especially pre-trends.
- Sensible robustness mindset overall.

### Critical weaknesses
- Identification from transposition timing is not yet convincing.
- Treatment timing likely poorly aligned with actual implementation and procurement exposure.
- Significant pre-trends materially weaken causal interpretation.
- Claims are sometimes stronger than the evidence supports.
- Robust estimators and sensitivity analysis reveal that precision is weaker than the headline TWFE estimates suggest.

### Publishability after revision
I think the paper is salvageable, but only with substantial redesign or reframing. The current draft is not close to acceptance at a top general-interest journal. The most promising path is either:
1. build a more credible implementation-based treatment and tighter design, or
2. explicitly reposition the paper as a careful reduced-form study of legal transposition timing with appropriately limited claims.

As it stands, the paper asks an excellent question and has the ingredients of a publishable study, but the empirical design is not yet persuasive enough for the causal conclusions the paper wants to draw.

**DECISION: MAJOR REVISION**